Article

Systemic taurine treatment provides neuroprotection against retinal photoreceptor…

Drug Design, Development and Therapy · 2019 · Tao Y, He M, Yang Q, Ma Z, Qu Y, Chen W, Peng G, Teng D

Key facts

Title Systemic taurine treatment provides neuroprotection against retinal photoreceptor degeneration and visual function impairments
First author Tao Y, He M, Yang Q, Ma Z, Qu Y, Chen W, Peng G, Teng D
Journal Drug Design, Development and Therapy
Published Aug 7, 2019
DOI 10.2147/DDDT.S194169
Devices mentioned K800552, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840, K920529, K920967, K923274 and 10 more
Product codes mentioned EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, KKX, JJP, LXH

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature